The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Intellia Therapeutics, Inc.
Portfolio Pulse from
The Schall Law Firm has announced a class action lawsuit against Intellia Therapeutics, Inc. for alleged securities fraud. The lawsuit claims violations of the Securities Exchange Act of 1934. Shareholders who purchased Intellia's securities between July 30, 2024, and January 8, 2025, are invited to join the case.
February 22, 2025 | 3:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Intellia Therapeutics is facing a class action lawsuit for alleged securities fraud, potentially impacting its stock price. Shareholders who bought during the specified period are encouraged to join the case.
The announcement of a class action lawsuit for securities fraud is likely to negatively impact Intellia's stock price in the short term. Legal issues can lead to investor uncertainty and potential financial liabilities.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100